Category:Response to Request for Additional Information (RAI)
MONTHYEARML17283A1092017-09-28028 September 2017
Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017
ML17265A0462017-09-19019 September 2017
Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit
ML17265A0472017-09-19019 September 2017
Response to the U.S. Nuclear Regulatory Commission, Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Preliminary Safety Analysis Report, Construction Permit Application
ML17265A0482017-09-18018 September 2017
Responses to Advisory Committee on Reactor Safeguard Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMI-2013-021, Construction Permit Application/Or Radioisotope Production, at Meetings on June 19, 2017; July 11, 2017; &
ML17128A0672017-04-28028 April 2017
NWMI-2017-RAI-002, Rev. 0, Response to the U.S. Nuclear Regulatory Commission Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Application for Construction Permit (TAC MF6138).
ML17128A0662017-04-28028 April 2017
Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017)
ML17128A0652017-04-28028 April 2017
Northwest Medical Isotopes, LLC Responses to the NRC Environmental Request for Additional Information - Letter Dated January 25, 2017
ML17093A6612017-03-0606 March 2017
Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017
ML16344A0532016-11-28028 November 2016
Northwest Medical Isotopes, LLC - Response to the U.S. Nuclear Regulatory Commission Request for Additional Information Regarding the Preliminary Safety Analysis Report and Environmental Review
ML16270A3772016-09-0101 September 2016
Northwest Medical Isotopes, LLC, Response to Environmental Request for Additional Information - Additional Clarification on POSA3-1A, POSA3-2A, POSA3-3A, NOI3-IB, and PA3-1
ML16210A3052016-07-18018 July 2016
Northwest Medical Isotopes, LLC, Response to Request for Additional Information Regarding Chapters 4, 13, and 19 of the Preliminary Safety Analysis Report and Environmental Review
ML16124A5102016-05-26026 May 2016
Summary of Telephone Conference Call Held on April 21, 2016, Between the U.S. Nuclear Regulatory Commission and Northwest Medical Isotopes, LLC Concerning Clarifications on Responses to Request for Additional Information for the Environment
ML16123A1192016-04-25025 April 2016
Northwest Medical Isotopes, LLC - Responses to the NRC Environmental Request for Additional Information - Letter Dated March 28, 2016
ML16053A2042016-02-12012 February 2016
Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 19, 2016
ML15328A0712015-11-20020 November 2015
Northwest Medical Isotopes, LLC - Response to the U.S. Nuclear Regulatory Commission Request for Additional Information, Environmental Review of the Construction Permit Application, Including Document No. NWMI-2015-RAI-001. Part 1 of 14
ML15328A0702015-11-20020 November 2015
Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated November 2, 2015
2017-09-28
[Table view] |